-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Neumora Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2022 to Q3 2025.
- Neumora Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 162M shares, a 1.42% increase year-over-year.
- Neumora Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 159M shares, a 145% increase from 2023.
- Neumora Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 65M shares, a 139% increase from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)